WGc-043
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WGc-043, covering 2025-06-19 to 2025-06-19. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I Study [Phase 1]